Skip to main content
Motivations and Experiences of Physicians Who Pursued Hemostasis and Thrombosis Fellowship - a Survey Study
Development and Validation of a Risk Assessment Model for Venous Thromboembolism in the Pediatric Intensive Care Unit
Clinician Adherence to Screening and Preventive Practices for Non-Malignant Late Effects Among Allogeneic Hematopoietic Cell Transplant Survivors in the United States.
Betibeglogene Autotemcel (beti-cel) Gene Addition Therapy Results in Durable Hemoglobin a Production with up to 10 Years of Follow-up with Transfusion-Dependent ß-Thalassemia.
Preclinical Activity of RAS(ON) Multi-Selective Inhibitor RMC-7977 and Therapeutic Combinations in AML with Signaling Mutations.
In Vivo and In Vitro Chemical Synthetic Lethality of ABHD17 and MEK Inhibition in NRAS -Mutant Acute Myeloid Leukemia.
HLA-Pan-DP CAR-T Demonstrates Cytotoxicity Against Multiple Hematological Malignancies.
Effective Azacytidine Monotherapy in an Infant with Mosaic NRAS-Driven JMML.
CDK8 Inhibition Represses Monocyte-like Gene Expression in Acute Myeloid Leukemia Cells and Antagonizes In Vivo Resistance to FLT3 Inhibition.
Application of Bone Mineral Density Study Guidelines across California Pediatric Oncology Survivorship Programs.